150 likes | 272 Views
Comparative Viral Fitness Assessment of Congenic Mutations Within an Immunodominant CD8+ T-cell Epitope of HIV. Natasha M. Christie 1 , David O. Willer 2,3 , Michael Lobritz 4 , Alan Cochrane 5 , Mark A. Luscher 2 , Eric J. Arts 4 , Kelly S. MacDonald 1,2,3.
E N D
Comparative Viral Fitness Assessment of Congenic Mutations Within an Immunodominant CD8+ T-cell Epitope of HIV Natasha M. Christie1, David O. Willer2,3, Michael Lobritz4, Alan Cochrane5, Mark A. Luscher2, Eric J. Arts4, Kelly S. MacDonald1,2,3 1-Department of Immunology, University of Toronto 2-Department of Medicine, University of Toronto 3-Department of Microbiology, Mt. Sinai Hospital, Toronto 4-Department of Molecular Biology and Microbiology, Case Western Reserve University 5-Department of Medical Genetics, University of Toronto
CD8+ T-cell Epitope Escape • Conflicting pressures on CD8+ T cell epitope sequences within the HIV-1 genome • Immune pressure Diversification • Viral Replication Conservation • Understanding these pressures is crucial for best selection of epitopes during vaccine design
SLYNTVATL (SL9) • Located in the matrix (p17) subunit of the Gag polyprotein • amino acid positions 77-85 in HIV genome • Response is immunodominant and sequence is highly conserved • Restricted by HLA-A2 • Multiple amino acid changes required to decrease immune recognition • Iversen A et al., Nat. Immunol., 2006
Questions… • In the face of such an immunodominant response, why is the epitope sequence conserved and CTL escape limited? • Is the constraint of this epitope sequence dictated by viral replication requirements?
Objective Investigate naturally occurring variants of SL9 to determine if viral replication is affected by amino acid changes in this epitope that alter immune recognition.
Natural SL9 Variant Evolution • Phylogenetic evidence of stepwise accumulation of mutations in A2+ individuals • Immunological evidence pointing to diminished recognition of triple mutant (Y3F/V6I/T8V) Iversen A et al. Nat. Immunol. 2006
Construction of SL9 Mutants • Focus on epitope variants defined as steps in the evolution of escape mutant sequences • Congenic mutations made in plasmid backbone of pLAI.2 using overlapping PCR • Commonly utilized infections clone of IIIB type virus; X4 tropism
Variant Panel shows decreased immune recognition
Experimental Approach • Plasmids transfected into 293T cells • Transfection supernatant passaged on U87.CD4.CXCR4 cells • TCID50 was determined using Karber method • Mono-infection assays in CEM-T4 cells using equal Multiplicity of Infection(MOI) of virus • p24 ELISA used to monitor viral replication
3/4 variants replicated at wild-type levels • Kinetic delay in T8V variant (p<0.005)
Higher levels of infecting virus do not overcome T8V kinetic delay
Conclusions • Naturally occurring variants of SLYNTVATL that diminish immune recognition do not necessarily correlate with decreased replicative capacity • T8V variant delayed kinetically but replicates at wild-type levels later in time course • No evident replication defect associated with Y3F/V6I/T8V variant
Viral Fitness • Viral fitnessreplicative capacity • Mono-infections not always representative • Moving forward with experiments in: • Primary cells • Competition assays
Interpretation • Restriction of variation in this sequence is not solely dictated by viral requirements • Balance of evolutionary pressures on this immunodominant epitope may be misunderstood • Conservation due to lack of immune pressure rather than viral importance?
Acknowledgements SupervisorsBiosafety Level 3 Lab Dr. Kelly MacDonald Dr. Jun Liu Dr. Mark Luscher Jennifer Biggs Construction of SL9 MutationsArts Lab Dr. David Willer Michael Lobritz University of Toronto, HIV Program Labs Branch Lab Dr. Rupert Kaul, Dr. Mario Ostrowski, Dr. Kelly MacDonald Nicole Lund Funding